New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 5

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Virol. Sep 25, 2021; 10(5): 275-287
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.275

Full Size Figure Download Figure

Figure 3 Prevalence of coronavirus disease 2019 associated hyperglycemia. COVID-19: Coronavirus disease 2019.

Citation: Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol 2021; 10(5): 275-287
URL: https://www.wjgnet.com/2220-3249/full/v10/i5/275.htm
DOI: https://dx.doi.org/10.5501/wjv.v10.i5.275

Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol 2021; 10(5): 275-287 [PMID: 34631477 DOI: 10.5501/wjv.v10.i5.275]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.